Wolverine Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-493
Closed -$346 1838
2024
Q1
$346 Hold
493
﹤0.01% 1584
2023
Q4
$862 Hold
493
﹤0.01% 1623
2023
Q3
$709 Hold
493
﹤0.01% 1728
2023
Q2
$1.28K Hold
493
﹤0.01% 1621
2023
Q1
$1.81K Hold
493
﹤0.01% 1665
2022
Q4
$872 Sell
493
-220
-31% -$585 ﹤0.01% 1958
2022
Q3
$2K Buy
+713
New +$4.38K ﹤0.01% 2275
2022
Q1
Sell
-2,729
Closed -$43K 2488
2021
Q4
$43K Buy
+2,729
New +$65.5K ﹤0.01% 1552
2021
Q3
Sell
-1,353
Closed -$56K 2450
2021
Q2
$56K Sell
1,353
-1,408
-51% -$57.8K ﹤0.01% 1637
2021
Q1
$140K Buy
+2,761
New +$144K ﹤0.01% 1351
2020
Q2
Sell
-656
Closed -$7K 1820
2020
Q1
$7K Buy
+656
New +$8.05K ﹤0.01% 1350

Other funds holding DMTK

Wolverine Asset Management's DMTK Position: Q2 2024 in Review

Wolverine Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 493 shares — an estimated $346 sold.

Wolverine Asset Management first reported a position in DMTK in Q1 2020 and held it in 11 quarters. The position peaked at $140K in Q1 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Wolverine Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 493 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $346.
  • Wolverine Asset Management first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Wolverine Asset Management's DermTech, Inc. Common Stock position peaked at $140K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.